Research Articles | Page 28 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MAC comp Sep 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia May 2020 Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation Aplastic Anemia
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Feb 2019 Biol Blood Marrow Transplant. Paroxysmal Nocturnal Hemoglobinuria (PNH)
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia Jan 2019 Biol Blood Marrow Transplant Aplastic Anemia
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology Myelodysplastic Syndromes (MDS)
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS)